Molecular Biosensor and Imaging Laboratory
The overarching theme of our research is translating molecular diagnostics for urological diseases from bench to bedside. Interfacing biology, engineering, medicine, and surgery, we aim to translate molecular biosensing and imaging technologies to the clinics with the goal of transforming the diagnosis and treatment of urological infections and cancers that are among the most common and expensive human diseases. We are particularly interested in harnessing the diagnostic potentials of urine using ultrasensitive molecular biosensors and incorporating optical and molecular imaging to improve the outcome of cancer surgery (i.e. image-guided surgery). Current projects include development of an integrated biochip for point-of-care diagnosis of urinary tract infections, in vivo microscopy of the urinary tract, and molecular contrast agents for optical imaging of bladder cancer.
We are part of the Stanford Department of Urology, the Stanford Cancer Institute, the Institute of Immunity, Transplantation, and Infection, and the Bio-X interdisciplinary program. Our funding support includes the National Cancer Institute (NCI), the National Institute of Allergy and Infectious Diseases (NIAID), the National Science Foundation (NSF), and the Department of Veterans Affairs (VA).